Authority and Permission Sample Clauses

Authority and Permission. The Applicant warrants that it has the authority and permission from the Multiple Listee to place this Multiple Listee in the listing report and directory. The applicant acknowledges that Intertek may provide notification to the Multiple Listee of changes affecting the product listing in the Directory. Intertek may confirm this Multiple Listee Registration information with the Multiple Listee.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Authority and Permission. As the parent or legal guardian of Participant, I have the authority to execute this Agreement on his/her behalf, and on behalf of any other parent or legal guardian of Participant, and I hereby grant my permission for Participant to use the RIM’s sports performance and personal training facilities and equipment (“the RIM”), and to participate in the RIM’s athletic programs and activities (“the RIM Activities”).
Sample 1
Authority and Permission. As the parent or legal guardian of the Participant, I have the authority to execute this Agreement on his/her behalf, and on behalf of any other parent or legal guardian of the Participant, and I hereby grant my permission for the Participant to use PG Facilities and to participate in PG Activities.
Sample 1
Authority and Permission. The Buyer has the full authority and permission required for signing this Agreement, and to perform and consummate its undertakings pursuant to this Agreement including its annexes and attachments. This Agreement, when signed by the Buyer, will constitute its legal, binding and valid undertaking.
Sample 1

Related to Authority and Permission

  • Consents and Permits Except as disclosed in the Registration Statement and the Prospectus, the Company and its Subsidiaries have made all filings, applications and submissions required by, possesses and is operating in compliance with, all approvals, licenses, certificates, certifications, clearances, consents, grants, exemptions, marks, notifications, orders, permits and other authorizations issued by, the appropriate federal, state or foreign Governmental Authority (including, without limitation, the United States Food and Drug Administration (the “FDA”), the United States Drug Enforcement Administration or any other foreign, federal, state, provincial, court or local government or regulatory authorities including self-regulatory organizations engaged in the regulation of clinical trials, pharmaceuticals, biologics or biohazardous substances or materials) necessary for the ownership or lease of their respective properties or to conduct its businesses as described in the Registration Statement and the Prospectus (collectively, “Permits”), except for such Permits the failure of which to possess, obtain or make the same would not have a Material Adverse Effect; the Company and its Subsidiaries are in compliance with the terms and conditions of all such Permits, except where the failure to be in compliance would not have a Material Adverse Effect; all of the Permits are valid and in full force and effect, except where any invalidity, individually or in the aggregate, would not be reasonably expected to have a Material Adverse Effect; and neither the Company nor any of its Subsidiaries has received any written notice relating to the limitation, revocation, cancellation, suspension, modification or non-renewal of any such Permit which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would have a Material Adverse Effect, or has any reason to believe that any such license, certificate, permit or authorization will not be renewed in the ordinary course. To the extent required by applicable laws and regulations of the FDA, the Company or the applicable Subsidiary has submitted to the FDA an Investigational New Drug Application or amendment or supplement thereto for each clinical trial it has conducted or sponsored or is conducting or sponsoring; all such submissions were in material compliance with applicable laws and rules and regulations when submitted and no material deficiencies have been asserted by the FDA with respect to any such submissions.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!